Back to Search
Start Over
Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus.
- Source :
- Annals of the Rheumatic Diseases; May2023, Vol. 82 Issue 5, p639-645, 7p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 00034967
- Volume :
- 82
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Annals of the Rheumatic Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 163734202
- Full Text :
- https://doi.org/10.1136/ard-2022-222748